Results 31 to 40 of about 3,036,943 (405)

The Impact of Whole-Body Vibration Training on Bone Minerals and Lean Mass in Children and Adolescents with Motor Disabilities: A Systematic Review and Meta-Analysis

Children, 2022
Whole-body vibration training (WBVT) offers a potential auxiliary treatment method for the rehabilitation of motor disabilities to address a reduction in bone minerals and lean mass caused by motor-disability rehabilitation. The aim of this review was to
Shuoqi Li, Wenbing Yu, Wei Li, Juncheng Wang, Lili Gao, Shiming Li   +5 more
doaj   +1 more source

Synchrotron imaging assessment of bone quality [PDF]

, 2016
Bone is a complex hierarchical structure and its principal function is to resist mechanical forces and fracture. Bone strength depends not only on the quantity of bone tissue but also on the shape and hierarchical structure.
Abel, RL, Boughton, O, Cobb, JP, Hansen, U, Jin, A, Karunaratne, A, Ma, S   +6 more
core   +1 more source

Change in bone mineral density in post menopausal women with rheumatoid arthritis [PDF]

, 2013
Introduction: Low bone mass is a serious complication of post menopausal women with rheumatoid arthritis. We determined the Change in Bone Mineral Density in postmenopausal women with rheumatoid arthritis.
Aghaei, M., Aili, A., Jamshir, M., Khani, S.H., Mohebi, E.G., Pour, N.B., Sedighi, S., Shirashiani, M., Shojaa, M., Zayeni, H.   +9 more
core   +1 more source

Chronic inflammation triggered by the NLRP3 inflammasome in myeloid cells promotes growth plate dysplasia by mesenchymal cells

Scientific Reports, 2017
Skeletal complications are common features of neonatal-onset multisystem inflammatory disease (NOMID), a disorder caused by NLRP3-activating mutations. NOMID mice in which NLRP3 is activated globally exhibit several characteristics of the human disease ...
Chun Wang, Can-Xin Xu, Yael Alippe, Chao Qu, Jianqiu Xiao, Ernestina Schipani, Roberto Civitelli, Yousef Abu-Amer, Gabriel Mbalaviele   +8 more
doaj   +1 more source

Knockout of TSC2 in Nav1.8+ neurons predisposes to the onset of normal weight obesity

Molecular Metabolism, 2023
Objective: Obesity and nutrient oversupply increase mammalian target of rapamycin (mTOR) signaling in multiple cell types and organs, contributing to the onset of insulin resistance and complications of metabolic disease. However, it remains unclear when
Jennifer M. Brazill, David Shin, Kristann Magee, Anurag Majumdar, Ivana R. Shen, Valeria Cavalli, Erica L. Scheller   +6 more
doaj   +1 more source

Evidence-based policy on dietary calcium and vitamin D [PDF]

, 2011
Copyright © 2011 American Society for Bone and Mineral Research.Peer ...
Abrahamsen, Bolland, Bolland, Committee to review dietary reference intakes for vitamin D and calcium, Curhan, Dawson-Hughes, Diamond, Reid, Reid, Reid, Tang, Tang, Wang   +12 more
core   +1 more source

Gasdermin D deficiency attenuates arthritis induced by traumatic injury but not autoantibody-assembled immune complexes

Arthritis Research & Therapy, 2021
Background Gasdermin D (GSDMD) is cleaved by several proteases including by caspase-1, a component of intracellular protein complexes called inflammasomes.
Tong Yang, Kai Sun, Chun Wang, Gaurav Swarnkar, Songtao Quan, Dustin Kress, Jianqiu Xiao, Yael Alippe, Hongjun Zheng, Robert H Brophy, Dingjun Hao, Audrey McAlinden, Yousef Abu-Amer, Jie Shen, Gabriel Mbalaviele   +14 more
doaj   +1 more source

Immunoporosis: Role of immune system in the pathophysiology of different types of osteoporosis

Frontiers in Endocrinology, 2022
Osteoporosis is a skeletal system disease characterized by low bone mass and altered bone microarchitecture, with an increased risk of fractures. Classical theories hold that osteoporosis is essentially a bone remodeling disorder caused by estrogen ...
Weidong Zhang, Weidong Zhang, Ruihan Gao, Ruihan Gao, Xing Rong, Xing Rong, Siqi Zhu, Siqi Zhu, Yajun Cui, Yajun Cui, Hongrui Liu, Hongrui Liu, Minqi Li, Minqi Li   +13 more
doaj   +1 more source

Romosozumab in postmenopausal women with low bone mineral density

New England Journal of Medicine, 2014
BACKGROUND Sclerostin is an osteocyte-derived inhibitor of osteoblast activity. The monoclonal antibody romosozumab binds to sclerostin and increases bone formation.
Sara L White
semanticscholar   +1 more source

Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis [PDF]

, 2006
BACKGROUND: Treatment with glucocorticoids is associated with bone loss starting soon after therapy is initiated and an increased risk of fracture. METHODS: We performed a randomized, double-placebo, double-blind clinical trial of 18 months' duration ...
Ale Algra, Anne-Margriet Huisman, Ans C.M. Oostveen, Ben A.C. Dijkmans, Chris E.D. de Laet, de Nijs RN, Erik Buskens, George A.W. Bruyn, Johannes W.G. Jacobs, Johannes W.J. Bijlsma, Michel BA, Piet P.M.M. Geusens, Roland F.J. Laan, Ron N.J. de Nijs, Willem F. Lems   +14 more
core   +4 more sources